文献速递免疫规划卫生政策与健康促进

美国老年人肺炎球菌疫苗接种的社会决定因素与接种率初步分析

Pneumococcal vaccination in older adults: An initial analysis of social determinants of health and vaccine uptake.
PubMed 文献 · Vaccine · 2020-07-10

本研究利用2013至2016年美国全国医保索赔数据,分析65岁及以上老年人接种肺炎球菌疫苗的社会决定因素。结果显示,联邦医保优势计划(Medicare Advantage)首年接种率为21.1%,按服务收费医保(fee-for-service)为38.2%;城市居住、健康素养高及民主党选民多的地区与更高接种几率相关,流感疫苗接种与肺炎球菌疫苗接种存在协同关系。

要点

  • 美国65岁老年人首年肺炎球菌疫苗接种率:医保优势计划21.1%,按服务收费医保38.2%。
  • 城市居住与更高接种几率相关(医保优势OR 1.31,按服务收费OR 1.53)。
  • 健康素养高、民主党选民多的地区与更高接种几率一致相关。

核心结论

  • 社会决定因素(如当地健康素养、贫困、居住于更自由派地区和信息获取)可能影响老年人肺炎球菌疫苗接种决策。
  • 需结合疫苗犹豫矩阵相关因素及更精细数据(如邮编级别)才能全面确定影响。

研究设计与样本

  • 回顾性队列研究,使用2013至2016年美国全国医保索赔数据。
  • 纳入65岁后首年并持续入组传统按服务收费医保或医保优势计划的老年人,观察门诊和药房肺炎球菌疫苗接种。
  • 样本量:医保优势计划307,488人,按服务收费医保74,995人。
  • 采用逻辑回归控制临床和人口学特征,分析社会决定因素预测因子。

主要发现

  • 医保优势计划首年接种率21.1%,按服务收费医保38.2%。
  • 城市地区接种几率更高:医保优势OR 1.31(95%CI 1.267-1.344),按服务收费OR 1.53(95%CI 1.450-1.615)。
  • 居住于健康素养更高地区或民主党选民更多社区与更高接种几率一致相关,不受医保类型影响。
  • 流感疫苗接种与肺炎球菌疫苗接种存在协同关系。

临床怎么用

  • 关注老年人肺炎球菌疫苗接种的社会决定因素,如城乡居住、地区健康素养和经济水平。
  • 利用流感疫苗接种机会协同促进肺炎球菌疫苗接种。

局限性

  • 需加入疫苗犹豫矩阵相关因素及更精细数据(如邮编级别)以全面确定影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To examine the potential influence of social determinants of health on pneumococcal vaccination in older American adults. METHODS: This study used nationwide, US Medicare claims data from 2013 to 2016 to assess uptake of pneumococcal vaccination among adults in the first year after turning age 65. Patients were followed from the point of being 65 years of age and initially enrolled in traditional fee-for-service Medicare or a Medicare Advantage plan through the subsequent year and observed for pneumococcal vaccination in outpatient clinics and pharmacies. Publicly-available data on select social determinants of health were incorporated and guided by the World Health Organization vaccine hesitancy matrix. Logistic regression determined predictors of vaccination while controlling clinical and demographic characteristics. RESULTS: A total of 307,488 and 74,995 adults aged 65 years were identified from Medicare Advantage and Medicare fee-for-service claims, respectively, and 21.1% of Medicare Advantage and 38.2% of Medicare fee-for-service patients received a pneumococcal vaccine in the first year after turning 65. Those residing in urban areas had a higher likelihood of pneumococcal vaccination in both the Medicare Advantage (OR: 1.31; 95% CI: 1.267-1.344) and Medicare fee-for-service (OR: 1.53; 95% CI: 1.450-1.615) cohorts. Additionally, residing in areas of higher health literacy or communities with more democratic voters were consistently associated with a higher odds of pneumococcal vaccination regardless of Medicare type. Results also pointed to a synergistic relationship between receiving the influenza vaccine and also being vaccinated against pneumococcal disease. CONCLUSION: Social determinants of health, including local health literacy, poverty, residing in more liberal areas, and access to information, may be influencing the pneumococcal vaccine-related decisions of older adults. However, additional factors associated with the vaccine hesitancy matrix and more granular data (e.g., zip code-level) are needed to fully determine the impact in this and other vaccines recommended in older adults.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gatwood J, Shuvo S, Hohmeier KC, et al. Pneumococcal vaccination in older adults: An initial analysis of social determinants of health and vaccine uptake. Vaccine. 2020. PMID: 32654903. doi:10.1016/j.vaccine.2020.06.077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。